Compare BIO & RRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | RRX |
|---|---|---|
| Founded | 1952 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.0B |
| IPO Year | 1994 | 1994 |
| Metric | BIO | RRX |
|---|---|---|
| Price | $366.63 | $175.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $356.67 | $232.20 |
| AVG Volume (30 Days) | 234.8K | ★ 1.2M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.78% |
| EPS Growth | ★ 142.61 | 42.86 |
| EPS | ★ 11.25 | 2.52 |
| Revenue | $2,583,200,000.00 | ★ $3,257,100,000.00 |
| Revenue This Year | N/A | $4.75 |
| Revenue Next Year | $1.86 | $12.95 |
| P/E Ratio | ★ $32.84 | $71.67 |
| Revenue Growth | 0.65 | ★ 5.21 |
| 52 Week Low | $236.73 | $127.96 |
| 52 Week High | $396.23 | $247.80 |
| Indicator | BIO | RRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.98 | 56.37 |
| Support Level | $354.27 | $148.19 |
| Resistance Level | $391.44 | $221.59 |
| Average True Range (ATR) | 13.26 | 9.12 |
| MACD | -0.39 | 1.81 |
| Stochastic Oscillator | 35.93 | 64.06 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.